# Comparing Psychiatric Outcomes in Cannabis Use Disorder and Other Substance Disorders > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/psychiatric-outcomes-cannabis-use-disorder-comparison/ > **Published:** 2026-03-04T14:58:50-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:11:48-04:00 > **Clinical Summary:** Explore psychiatric outcomes cannabis use disorder comparison with other substance use disorders to inform clinical screening and treatment strategies. --- ✦ New CED Clinical Relevance** #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. Mental HealthResearchSafetyTHCPolicy Why This Matters Patients who use cannabis heavily should know that research is actively examining how [cannabis use disorder](https://cedclinic.com/sex-differences-cannabis-stress-reactivity-oxytocin/) compares to other [substance use disorders](https://cedclinic.com/cannabinoid-clinical-trials-mental-disorders-evidence-2/) in terms of real-world psychiatric risks, which may affect how clinicians screen and counsel them going forward. Clinical Summary Research comparing [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) disorder to other substance use disorders is an important area of inquiry because it helps clinicians understand the relative psychiatric burden associated with problematic cannabis use in the context of a rapidly changing legal and cultural landscape. Propensity-score-matched study designs are valuable here because they attempt to control for the many confounding variables that make substance use populations inherently difficult to compare fairly. Understanding how cannabis use disorder stacks up against alcohol, opioid, or stimulant use disorders in terms of psychiatric outcomes can meaningfully inform screening, treatment prioritization, and [public health](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/) messaging. Dr. Caplan’s Take “Comparing cannabis use disorder to other substance use disorders using matched data is the right methodological move, but the conclusions are only as useful as our willingness to act on them clinically rather than treat cannabis as categorically safer by default.” Clinical Perspective This propensity-score-matched analysis from TriNetX provides valuable real-world data on how cannabis use disorder compares to other substance use disorders in psychiatric outcomes and comorbidity patterns. Understanding these distinctions matters clinically, as cannabis use disorder often presents alongside other psychiatric conditions in ways that may differ from alcohol or opioid use disorders. The matching methodology helps isolate cannabis-specific associations while controlling for confounding variables that typically complicate substance use research. These findings can inform differential diagnostic approaches and help clinicians better anticipate which patients with cannabis use disorder may need integrated mental health interventions. Large administrative databases like TriNetX offer an important complement to smaller clinical studies by revealing patterns across diverse healthcare settings. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Association+of+%3Cb%3ECannabis%3C%2Fb%3E+Use+Disorder+Versus+Other+Substance+Use+Disorders+...+-+Psychiatry+On...+%40drcaplan&url=https%3A%2F%2Fpsychiatryonline.org%2Fdoi%2F10.1176%2Fappi.ajp.20250336) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fpsychiatryonline.org%2Fdoi%2F10.1176%2Fappi.ajp.20250336) [🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Association+of+%3Cb%3ECannabis%3C%2Fb%3E+Use+Disorder+Versus+Other+Substance+Use+Disorders+...+-+Psychiatry+On...+%E2%80%94+via+%40drcaplan.bsky.social+https%3A%2F%2Fpsychiatryonline.org%2Fdoi%2F10.1176%2Fappi.ajp.20250336) [📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/) [📝 Read more on Substack](https://substack.com/@doctorapproved) [🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - [Link between cannabis and anxiety, depression has ‘strengthened over time’ – NY Post](https://cedclinic.com/strengthening-cannabis-anxiety-link/) - [What effects does THC** have on youth who dabble? – YouTube](https://cedclinic.com/effects-thc-adolescent-brain-development/) 📰 Source: [https://psychiatryonline.org/doi/10.1176/appi.ajp.20250336](https://psychiatryonline.org/doi/10.1176/appi.ajp.20250336) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabis Use Disorder Strongly Linked to Major Depression, New Review Finds](https://cedclinic.com/cannabis-use-disorder-strongly-linked-to-major-depression-new-review-finds/) This review highlights the strong association between cannabis use disorder and major depression, providing important context for psychiatric outcomes. [Read the review](https://cedclinic.com/cannabis-use-disorder-strongly-linked-to-major-depression-new-review-finds/) [New Clinical Insights on Cannabis and Patient Outcomes](https://cedclinic.com/new-clinical-insights-on-cannabis-and-patient-outcomes/) Explore recent clinical insights on cannabis use and its impact on patient outcomes, including psychiatric considerations. [Explore insights](https://cedclinic.com/new-clinical-insights-on-cannabis-and-patient-outcomes/) What Doctors Want You to Know About [Cannabis and Health](https://cedclinic.com/gateway-drug-myth/) – The New York Times An informative article summarizing key medical perspectives on cannabis and health, relevant to understanding psychiatric risks. Learn more ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).